For years we along with many others have been clamoring for outcomes to truly matter. That how wonderful and impactful it would be if better outcomes actually mattered not just to patients and their physicians but to payors. Keep in mind when it comes to any piece of diabetes technology or any drug not much is going to happen unless it gets into the hands of patients and payors control this critical piece of the diabetes food chain. And unless we missed something payors still care about one thing and one thing only, money.
Even with these so-called value . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.